Elevance Health (ELV) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $428.43, +0.08% vs the prior close of $428.09.
- Volume 1.52M shares, 1.4x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ELV ends flat (+0.1%) to $428.43, a 52-week high, 5 up days in a row. Closed at $428.43, +0.08% vs the prior close of $428.09. Day range $424.87–$432.26, opened at $429.00.
ELV daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — ELV ends flat (+0.1%) to $428.43, a 52-week high, 5 up days in a row
- Closed at $428.43, +0.08% vs the prior close of $428.09. Day range $424.87–$432.26, opened at $429.00.
- Volume was 1.52M shares, 1.4x its 50-day average of 1.10M.
- Price is +6.3% vs its 50-day average ($403.11) and +16.2% vs its 200-day average ($368.82).
- 52-week range $274.84–$436.24; today's close sits at 95% of that range, 1.8% below the 52-week high.
- That makes 5 straight gains.
Oct 14, 2026 — ELV rises 0.7% to $428.09, a 52-week high on 1.9x normal volume
- Closed at $428.09, +0.66% vs the prior close of $425.27. Day range $421.78–$434.00, opened at $428.82.
- Volume was 2.12M shares, 1.9x its 50-day average of 1.09M — unusually heavy trading.
- Price is +6.4% vs its 50-day average ($402.36) and +16.2% vs its 200-day average ($368.42).
- 52-week range $274.84–$436.24; today's close sits at 95% of that range, 1.9% below the 52-week high.
- That makes 4 straight gains.
Oct 13, 2026 — ELV rises 0.8% to $425.27, a 3-month high, 3 up days in a row
- Closed at $425.27, +0.75% vs the prior close of $422.09. Day range $420.99–$433.89, opened at $427.00.
- Volume was 1.84M shares, 1.7x its 50-day average of 1.07M.
- Price is +6.0% vs its 50-day average ($401.36) and +15.6% vs its 200-day average ($368.03).
- 52-week range $274.84–$436.24; today's close sits at 93% of that range, 2.5% below the 52-week high.
- That makes 3 straight gains.
Oct 12, 2026 — ELV rises 2.3% to $422.09
- Closed at $422.09, +2.28% vs the prior close of $412.70. Day range $413.70–$423.98, opened at $415.00.
- Volume was 869.50K shares, 0.8x its 50-day average of 1.08M.
- Price is +5.4% vs its 50-day average ($400.51) and +14.8% vs its 200-day average ($367.62).
- 52-week range $274.84–$436.24; today's close sits at 91% of that range, 3.2% below the 52-week high.
Oct 9, 2026 — ELV rises 2.9% to $412.70 on 2.0x normal volume
- Closed at $412.70, +2.93% vs the prior close of $400.94. Day range $400.94–$418.56, opened at $401.92.
- Volume was 2.08M shares, 2.0x its 50-day average of 1.05M — unusually heavy trading.
- Price is +3.3% vs its 50-day average ($399.59) and +12.4% vs its 200-day average ($367.23).
- 52-week range $274.84–$436.24; today's close sits at 85% of that range, 5.4% below the 52-week high.
Oct 8, 2026 — ELV dips 0.8% to $400.94
- Closed at $400.94, -0.83% vs the prior close of $404.31. Day range $397.12–$407.37, opened at $403.83.
- Volume was 785.80K shares, 0.7x its 50-day average of 1.06M.
- Price is +0.5% vs its 50-day average ($398.86) and +9.3% vs its 200-day average ($366.88).
- 52-week range $274.84–$436.24; today's close sits at 78% of that range, 8.1% below the 52-week high.
Oct 7, 2026 — ELV rises 1.1% to $404.31, 4 up days in a row
- Closed at $404.31, +1.05% vs the prior close of $400.09. Day range $399.98–$410.54, opened at $401.00.
- Volume was 904.80K shares, 0.8x its 50-day average of 1.07M.
- Price is +1.5% vs its 50-day average ($398.36) and +10.3% vs its 200-day average ($366.58).
- 52-week range $274.84–$436.24; today's close sits at 80% of that range, 7.3% below the 52-week high.
- That makes 4 straight gains.
Oct 6, 2026 — ELV rises 1.4% to $400.09, 3 up days in a row
- Closed at $400.09, +1.41% vs the prior close of $394.51. Day range $394.42–$400.97, opened at $396.68.
- Volume was 1.23M shares, 1.1x its 50-day average of 1.07M.
- Price is +0.5% vs its 50-day average ($397.99) and +9.2% vs its 200-day average ($366.28).
- 52-week range $274.84–$436.24; today's close sits at 78% of that range, 8.3% below the 52-week high.
- That makes 3 straight gains.
Oct 5, 2026 — ELV rises 2.1% to $394.51
- Closed at $394.51, +2.09% vs the prior close of $386.43. Day range $385.00–$395.99, opened at $387.67.
- Volume was 712.10K shares, 0.7x its 50-day average of 1.08M.
- Price is -0.8% vs its 50-day average ($397.56) and +7.8% vs its 200-day average ($366.01).
- 52-week range $274.84–$436.24; today's close sits at 74% of that range, 9.6% below the 52-week high.
Oct 2, 2026 — ELV rises 1.2% to $386.43
- Closed at $386.43, +1.25% vs the prior close of $381.67. Day range $380.65–$388.04, opened at $382.09.
- Volume was 892.70K shares, 0.8x its 50-day average of 1.08M.
- Price is -2.7% vs its 50-day average ($397.22) and +5.6% vs its 200-day average ($365.80).
- 52-week range $274.84–$436.24; today's close sits at 69% of that range, 11.4% below the 52-week high.
ELV latest news & SEC filings
Every SEC filing by or about ELV in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 6, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kaye Mark had withheld for taxes 4,161 shares at $386.43 (≈$1.61M) on Oct 2, 2026; now holds 27,876
- Kaye Mark received an award of 2,627 shares on Oct 2, 2026; now holds 30,503
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 10, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 4, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 4, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 17, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Peru Ramiro G bought 1,000 shares at $366.05 (≈$366.05K) on Jul 17, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 17, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Boudreaux Gail bought 680 shares at $366.41 (≈$249.16K) on Jul 17, 2026
- Boudreaux Gail bought 2,045 shares at $368.25 (≈$753.07K) on Jul 17, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 15, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $50.47B (prior year $49.78B) (+1.4% vs Jun 30, 2025)
- Net income: $1.46B (prior year $1.74B) (-16.1% vs Jun 30, 2025)
- Diluted EPS: $6.71 (prior year $7.72) (-13.1% vs Jun 30, 2025)
Jul 15, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 7, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Things to know before you trade ELV
- Last results release: Jul 15, 2026 (8-K Item 2.02). Previous ones: Apr 22, 2026, Jan 28, 2026, Oct 21, 2025. Based on that rhythm, the next report is likely around Oct 14, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.07% (largest 2.9%).
- Liquidity: about 1.27M shares (≈$544.74M) trade per day on average.
- 52-week position: $428.43 vs a range of $274.84–$436.24 (95% of the range).
- Dividends: last ex-dividend date Sep 10, 2026 ($1.72/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 5 sales; latest: Gail Boudreaux bought 680 shares on Jul 17, 2026.
- Latest filings: 8-K Sep 10, 2026; 10-Q Jul 15, 2026; 8-K Jul 15, 2026.
- Share count: 216.87M shares outstanding (Jul 10, 2026), -3.7% vs a year earlier — the company has been reducing its share count.
- Listing: NYSE · industry: Hospital & Medical Service Plans.
ELV market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 429.00 | 432.26 | 424.87 | 428.43 | 1.52M |
| Oct 14, 2026 | 428.82 | 434.00 | 421.78 | 428.09 | 2.12M |
| Oct 13, 2026 | 427.00 | 433.89 | 420.99 | 425.27 | 1.84M |
| Oct 12, 2026 | 415.00 | 423.98 | 413.70 | 422.09 | 869.50K |
| Oct 9, 2026 | 401.92 | 418.56 | 400.94 | 412.70 | 2.08M |
| Oct 8, 2026 | 403.83 | 407.37 | 397.12 | 400.94 | 785.80K |
| Oct 7, 2026 | 401.00 | 410.54 | 399.98 | 404.31 | 904.80K |
| Oct 6, 2026 | 396.68 | 400.97 | 394.42 | 400.09 | 1.23M |
| Oct 5, 2026 | 387.67 | 395.99 | 385.00 | 394.51 | 712.10K |
| Oct 2, 2026 | 382.09 | 388.04 | 380.65 | 386.43 | 892.70K |
| Oct 1, 2026 | 388.00 | 390.37 | 375.74 | 381.67 | 1.19M |
| Sep 30, 2026 | 391.91 | 396.14 | 383.04 | 388.82 | 1.30M |
| Sep 29, 2026 | 391.00 | 395.44 | 390.00 | 392.73 | 934.80K |
| Sep 28, 2026 | 396.99 | 400.17 | 392.44 | 394.59 | 1.33M |
| Sep 25, 2026 | 400.00 | 405.13 | 394.69 | 396.09 | 1.22M |
| Sep 24, 2026 | 397.00 | 400.97 | 394.31 | 398.25 | 1.17M |
| Sep 23, 2026 | 400.84 | 404.39 | 396.37 | 398.56 | 1.21M |
| Sep 22, 2026 | 412.07 | 412.75 | 401.38 | 402.43 | 1.12M |
| Sep 21, 2026 | 410.31 | 411.48 | 406.20 | 409.31 | 934.00K |
| Sep 18, 2026 | 414.68 | 415.36 | 406.38 | 410.95 | 2.07M |
About Elevance Health
Elevance Health (ELV) is listed on the NYSE and classified by the SEC under “Hospital & Medical Service Plans”. Its business address is in INDIANAPOLIS, IN. State of incorporation: IN. Fiscal year ends December 31. SEC CIK 1156039.
ELV board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Gail Boudreaux | President and CEO | Jul 17, 2026 |
| Steven H Collis | Director | May 15, 2026 |
| Susan D. Devore | Director | May 15, 2026 |
| Robert L Jr Dixon | Director | Jun 12, 2026 |
| Lewis Iii Hay | Director | May 15, 2026 |
| Bahija Jallal | Director | May 15, 2026 |
| Antonio F Neri | Director | May 15, 2026 |
| Ramiro G Peru | Director | Jul 17, 2026 |
| Amy W Schulman | Director | May 15, 2026 |
| Deanna D Strable-Soethout | Director | May 15, 2026 |
| Ryan M. Schneider | Director | May 15, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Gail Boudreaux | President and CEO | Jul 17, 2026 |
| Ryan R Craig | EVP & Chief HR Officer | Sep 4, 2026 |
| Peter D Haytaian | EVP & Pres Carelon & CarelonRx | Mar 4, 2026 |
| Mark Kaye | EVP & CFO | Mar 4, 2026 |
| Charles Morgan Jr Kendrick | EVP & President, Commercial | Mar 9, 2026 |
| Ratnakar Lavu | EVP & Chief Digital Info Ofr | Mar 4, 2026 |
| Felicia F Norwood | EVP &Chief Health Benefits Ofr | Mar 4, 2026 |
| Ronald W Penczek | CAO & Controller | Jun 15, 2026 |
| Erin M Wessling | EVP & Chief Legal Officer | Sep 4, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 17, 2026 | Gail Boudreaux | Buy | 680 | $366.41 |
| Jul 17, 2026 | Gail Boudreaux | Buy | 2,045 | $368.25 |
| Jul 17, 2026 | Ramiro G Peru | Buy | 1,000 | $366.05 |
| Jun 12, 2026 | Ronald W Penczek | Sale | 369 | $403.16 |
| Jun 11, 2026 | Robert L Jr Dixon | Sale | 151 | $401.77 |
| May 19, 2026 | Ronald W Penczek | Sale | 1,531 | $403.13 |
| Mar 12, 2026 | Amy W Schulman | Sale | 26 | $287.50 |
| Mar 6, 2026 | Charles Morgan Jr Kendrick | Sale | 3,196 | $284.92 |
| Mar 5, 2026 | Steven H Collis | Buy | 3,000 | $289.84 |
ELV financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $199.12B | $5.66B | 25.21 | $4.29B |
| Dec 31, 2024 | $177.01B | $5.98B | 25.68 | $5.81B |
| Dec 31, 2023 | $171.34B | $5.99B | 25.22 | $8.06B |
| Dec 31, 2022 | $156.59B | $5.89B | 24.28 | $8.40B |
| Dec 31, 2021 | $138.64B | $6.16B | 24.95 | $8.36B |
Latest balance sheet: total assets $126.44B, total liabilities $81.42B, cash $10.23B (as of Jun 30, 2026).
ELV earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 15, 2026 | 8-K Item 2.02 (results) | $390.33 |
| Apr 22, 2026 | 8-K Item 2.02 (results) | $328.20 |
| Jan 28, 2026 | 8-K Item 2.02 (results) | $341.85 |
| Oct 21, 2025 | 8-K Item 2.02 (results) | $349.75 |
| Jul 17, 2025 | 8-K Item 2.02 (results) | $302.45 |
| Apr 22, 2025 | 8-K Item 2.02 (results) | $415.90 |
| Apr 17, 2025 | 8-K Item 2.02 (results) | $424.53 |
| Jan 23, 2025 | 8-K Item 2.02 (results) | $401.36 |
| Oct 17, 2024 | 8-K Item 2.02 (results) | $444.35 |
| Jul 17, 2024 | 8-K Item 2.02 (results) | — |
| Apr 18, 2024 | 8-K Item 2.02 (results) | — |
| Jan 24, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Hospital & Medical Service Plans
UnitedHealth (UNH)Cigna (CI)Humana (HUM)Centene (CNC)Oscar Health (OSCR)Molina Healthcare (MOH)Alignment Healthcare (ALHC)Clover Health Investments (CLOV)Trupanion (TRUP)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on ELV
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.